{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:11:24Z","timestamp":1779196284680,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>VEXAS syndrome is a rare, adult-onset autoinflammatory disorder caused by somatic mutations in the UBA1 gene. Patients may present with symptoms similar to IgG4-related disease (IgG4-RD) or systemic vasculitis. We report the case of a 70-year-old man who presented with periorbital swelling, fever, and elevated serum IgG4. However, a biopsy of the lacrimal gland did not show histological evidence of IgG4-RD. Consecutively, the patient developed progressive pulmonary infiltrations, bicytopenia and leukocytoclastic vasculitis. Chest-CT showed organizing pneumonia, which was histologically proven by transbronchial lung cryobiopsy (TBLC), again excluding IgG4-RD. PET\/CT revealed hypermetabolic bone marrow and bone marrow aspiration biopsy showed vacuolization of granulocytic precursor cells. Finally, genetic testing for UBA1 mutation confirmed the diagnosis of VEXAS syndrome. Treatment with ruxolitinib in addition to steroids, led to temporary stabilization but long-term prognosis was unfavorable. This case highlights the importance of considering VEXAS syndrome a relevant differential diagnosis of vasculitis and IgG4-RD in men. Furthermore, we present valuable insights into the pathophysiology of VEXAS through transmission electron microscopy (TEM) of TBLC samples.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1742328","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:35:19Z","timestamp":1768973719000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Diagnostic challenges in VEXAS syndrome with novel ultrastructural lung findings: IgG4-RD and vasculitis as relevant differential diagnoses"],"prefix":"10.3389","volume":"16","author":[{"given":"Peter","family":"Etzel","sequence":"first","affiliation":[{"name":"Johannes Kepler University Linz, Kepler University Hospital, Department of Pulmonology","place":["Linz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lang","sequence":"additional","affiliation":[{"name":"Johannes Kepler University Linz, Kepler University Hospital, Department of Pulmonology","place":["Linz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Stoiber","sequence":"additional","affiliation":[{"name":"Department of Environment and Biodiversity \u2013 EM Core Facility, University of Salzburg","place":["Salzberg, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Obermayer","sequence":"additional","affiliation":[{"name":"Department of Environment and Biodiversity \u2013 EM Core Facility, University of Salzburg","place":["Salzberg, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"\u00d6berseder","sequence":"additional","affiliation":[{"name":"Kepler University Hospital, Department of Rheumatology","place":["Linz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Lamprecht","sequence":"additional","affiliation":[{"name":"Johannes Kepler University Linz, Kepler University Hospital, Department of Pulmonology","place":["Linz, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.24836","article-title":"Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population","volume":"329","author":"Beck","year":"2023","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-251089","article-title":"VEXAS syndrome with progression of MDS to MDS\/MPN overlap syndrome","volume":"15","author":"Neupane","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and Malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.43287","article-title":"American college of rheumatology guidance statement for diagnosis and management of VEXAS developed by the international VEXAS working group expert panel","author":"Mekinian","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226970","article-title":"VEXAS syndrome: A comprehensive review of current therapeutic strategies and emerging treatments","volume":"13","author":"AlQatari","year":"2024","journal-title":"J Clin Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.02.022","article-title":"Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome","volume":"23","author":"Goyal","year":"2022","journal-title":"JAAD Case Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in VEXAS syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS","volume":"149","author":"van der Made","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107245","article-title":"Pulmonary manifestations in VEXAS syndrome","volume":"213","author":"Casal Moura","year":"2023","journal-title":"Respir Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17679","article-title":"Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold","volume":"195","author":"Lacombe","year":"2021","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1325157","article-title":"Cryptogenic organizing pneumonia","volume":"33","author":"Cottin","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2023.01020","article-title":"VEXAS syndrome: Current clinical, diagnostic and treatment approaches","volume":"12","author":"Kobak","year":"2023","journal-title":"Intractable Rare Dis Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5114\/reum\/163090","article-title":"VEXAS syndrome: a newly discovered systemic rheumatic disorder","volume":"61","author":"Kucharz","year":"2023","journal-title":"Reumatologia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2023.100242","article-title":"VEXAS syndrome-diagnostic clues for the dermatologist and gaps in our current understanding: A narrative review","volume":"4","author":"Nicholson","year":"2024","journal-title":"JID Innov"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1466720","article-title":"Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis","volume":"15","author":"Baggio","year":"2024","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead240","article-title":"How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies","volume":"62","author":"Boyadzhieva","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678927","article-title":"Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome","volume":"12","author":"Staels","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2011.0518","article-title":"Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis","volume":"86","author":"Tefferi","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002484","article-title":"The VEXAS syndrome: uncontrolled inflammation and macrocytic anaemia in a 77-year-old male patient","volume":"8","author":"Himmelmann","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016642","article-title":"Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study","volume":"140","author":"Heiblig","year":"2022","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022329","article-title":"Venous and arterial thrombosis in patients with VEXAS syndrome","volume":"143","author":"Kusne","year":"2024","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12931-024-02981-1","article-title":"Transmission electron microscopy of transbronchial lung cryobiopsy samples in a cohort of fibrotic interstitial lung disease patients - feasibility and implications of endothelial alterations","volume":"25","author":"Lang","year":"2024","journal-title":"Respir Res"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1805595","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1742328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:34:27Z","timestamp":1779194067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1742328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2025.1742328"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1742328","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1742328"}}